Wellness Product Launches: Equelle For Menopause, Renadyl For Uremic Toxins, More
Executive Summary
S-equol in Equelle menopause supplement; antioxidant support for PTSD symptoms; supplement targets uremic toxins; green tea for heart health; and CartiJoint with Bio-Curcumin Curcugree.
You may also be interested in...
Research Bonafides, Detailing Gynecologists Included In Pharmavite's Third Women’s Health Line
“This acquisition, plus our existing women's health brands of Equelle and Uqora, positions us, the combined group, as the leader in women's health in nutraceuticals in the US,” says Pharmavite CEO Jeff Boutelle. Bonafide markets supplements for long-term, sustainable support for needs that compound with age, including hot flashes, vaginal dryness, vaginal microbiome and sexual satisfaction.
Pharmavite Moves Into OTCs With Uqora Acquisition To Expand Women’s Health Lineup
Pharmavite acquires Uqora, a startup marketing supplements, OTCs and devices to prevent or treat urinary tract infections. Moving into the category adds a growth driver as UTIs are the most common bacterial infection requiring medical care in the US.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.